BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6336892)

  • 1. Triad of glomerulonephritis, antinuclear antibodies, and positive skin immunofluorescence. Variant of systemic lupus erythematosus.
    Ascer K; Walker JA; Lief PD; Barland P; Bank N
    Am J Med; 1983 Jan; 74(1):83-9. PubMed ID: 6336892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of lupus nephritis by skin immunofluorescence, in the absence of extrarenal manifestations of systemic lupus erythematosus.
    Lief PD; Barland P; Bank N
    Am J Med; 1977 Sep; 63(3):441-8. PubMed ID: 331949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin classes in skin basement membrane in systemic lupus erythematosus: clinical significance and comparison with classes of serum anti-DNA antibodies.
    Bresnihan B; Hale GM; Bunn CC; Hughes GR
    Ann Rheum Dis; 1979 Aug; 38(4):351-5. PubMed ID: 315209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.
    Christian N; Smikle MF; DeCeulaer K; Daniels L; Walravens MJ; Barton EN
    West Indian Med J; 2007 Mar; 56(2):130-3. PubMed ID: 17910142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A significant increase of HLA-DR3 and DR2 in systemic lupus erythematosus among blacks.
    Kachru RB; Sequeira W; Mittal KK; Siegel ME; Telischi M
    J Rheumatol; 1984 Aug; 11(4):471-4. PubMed ID: 6332908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between antibodies to dsDNA and to soluble cellular antigens and histologically defined glomerulonephritis in patients with SLE.
    Asero R; Banfi G; Radelli L; Origgi L; Bertetti E; Vanoli M; Riboldi P
    Autoimmunity; 1990; 7(1):13-21. PubMed ID: 2103306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.
    Cairns SA; Acheson EJ; Corbett CL; Dosa S; Mallick NP; Lawler W; Williams G
    Postgrad Med J; 1979 Oct; 55(648):723-7. PubMed ID: 317153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
    Carlo JR; Rothfield NF; Ruddy S
    Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin class of anti-DNA antibodies: detection by a fluorometric immunoassay: clinical and pathological correlations in SLE.
    Ross GL; Barland P; Grayzel AI
    J Rheumatol; 1978; 5(4):373-83. PubMed ID: 368334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters.
    Lowenstein MB; Rothfield NF
    Arthritis Rheum; 1977; 20(7):1293-1303. PubMed ID: 334183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens associated with systemic lupus erythematosus in Japan.
    Hashimoto H; Tsuda H; Matsumoto T; Nasu H; Takasaki Y; Shokawa Y; Hirose S; Terasaki PI; Iwaki Y
    J Rheumatol; 1985 Oct; 12(5):919-23. PubMed ID: 3878879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.
    Roberts JL; Schwartz MM; Lewis EJ
    Clin Exp Immunol; 1978 Feb; 31(2):328-38. PubMed ID: 348363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus.
    Tron F; Bach JF
    Clin Exp Immunol; 1977 Jun; 28(3):426-32. PubMed ID: 302165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin immunofluorescence patterns in SLE patients in Singapore.
    Ratnam KV; Phay KL; Ng SK; Tan T
    Singapore Med J; 1987 Dec; 28(6):517-9. PubMed ID: 3327168
    [No Abstract]   [Full Text] [Related]  

  • 18. Antinuclear antibody-negative systemic lupus erythematosus: loss in body fluids.
    Persellin RH; Takeuchi A
    J Rheumatol; 1980; 7(4):547-50. PubMed ID: 6999153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of subepidermal immune deposits in uninvolved skin of patients with systemic lupus erythematosus: a 10-year longitudinal study.
    Davis BM; Gilliam JN
    J Invest Dermatol; 1984 Oct; 83(4):242-7. PubMed ID: 6384375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.